Bioresponsive drug delivery depot for epigenetic modulation and immune checkpoint blockade
基本信息来源于合作网站,原文需代理用户跳转至来源网站获取
摘要:
With the support by the National Natural Science Foundation of China,the research teams directed by Prof.Lu WeiYue (陆伟跃) at the Department of Pharmaceutics,School of Pharmacy,Key Laboratory of Smart Drug Delivery,Fudan University and Prof.Gu Zhen (顾臻) at the Department of Bioengineering,University of California,Los Angeles (UCLA),recently reported an in situ formed bioresponsive depot for combination of epigenetic modulation and immune checkpoint blockade,which was published in Advanced Materials as a front cover (2019,1806957).